Patient harboring a novel PIK3CA point mutation after acquired resistance to crizotinib in an adenocarcinoma with ROS1 rearrangement: A case report and literature review
Xu, Chun-wei, Wang, Wen-xian, Huang, Rong-fang, He, Cheng, Liao, Xing-hui, Zhu, You-cai, Du, Kai-qi, Zhuang, Wu, Chen, Yan-ping, Chen, Gang, Fang, Mei-yuLanguage:
english
Journal:
Thoracic Cancer
DOI:
10.1111/1759-7714.12496
Date:
August, 2017
File:
PDF, 790 KB
english, 2017